October 20, 2023 – Bausch Health Companies Inc. and its dermatology business, Ortho Dermatologics, have
announced that the U.S. Food and Drug Administration
October 19, 2023 - Apotex Corp.; Sun Pharmaceutical Industries, Inc.; Teva Pharmaceuticals USA, Inc., have
been approved by the FDA for the use of Pazopanib Hydrochloride Tablets
October 18, 2023 - UCB, a global biopharmaceutical company, has announced that the U.S. Food and Drug
Administration (FDA) has approved BIMZELX ® (bimekizumab-bkzx)
October 18, 2023 - Hyloris Pharmaceuticals SA), today announced Maxigesic® IV has been approved for the
relief of mild to moderate pain and for the management
October 18, 2023 - Orasis Pharmaceuticals, , today announced that the U.S. Food and Drug Administration
(FDA) has approved QlosiTM (pilocarpine hydrochloride ophthalmic
October 17, 2023 - The U.S. Food and Drug Administration approved Velsipity (etrasimod) for adults with
moderately to severely active ulcerative colitis (UC). Velsipity provides adults living with
October 17, 2023 - Ardelyx, Inc., a biopharmaceutical company, has announced that the U.S. Food and
Drug Administration (FDA) has approved Xphozah (tenapanor)
October 17, 2023 – UCB, a global biopharmaceutical company, today announced that Zilbrysq® (zilucoplan)
has been approved by the U.S. Food and Drug Administration (FDA)